184 related articles for article (PubMed ID: 32776380)
1. Linezolid and the risk of lactic acidosis: Data mining and analysis of the FDA Adverse Event Reporting System.
Dai Y; Wang Y; Zeng Y; Zhang C; Zhou Z; Shi D
J Clin Pharm Ther; 2020 Dec; 45(6):1422-1426. PubMed ID: 32776380
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of lactic acidosis induced by linezolid and vancomycin therapy using cohort and case-control studies of incidence and associated risk factors.
Mori N; Kamimura Y; Kimura Y; Hirose S; Aoki Y; Bito S
Eur J Clin Pharmacol; 2018 Apr; 74(4):405-411. PubMed ID: 29222713
[TBL] [Abstract][Full Text] [Related]
3. Linezolid and the risk of QT interval prolongation: A pharmacovigilance study of the Food and Drug Administration Adverse Event Reporting System.
Shao H; Shi D; Dai Y
Br J Clin Pharmacol; 2023 Apr; 89(4):1386-1392. PubMed ID: 36346345
[TBL] [Abstract][Full Text] [Related]
4. Lactic Acidosis and Thrombocytopenia Associated with Linezolid Therapy: A Case Report.
Xiao B; Deng P; Jin H; Wang H; Cao Y
Am J Case Rep; 2018 Sep; 19():1117-1120. PubMed ID: 30232318
[TBL] [Abstract][Full Text] [Related]
5. [Verification of Relationship between Administration of Linezolid and Vomiting].
Tsutsumi T; Imai S; Yamada K; Yamada T; Kasashi K; Kobayashi M; Iseki K
Yakugaku Zasshi; 2019; 139(7):1055-1061. PubMed ID: 31257252
[TBL] [Abstract][Full Text] [Related]
6. Serious adverse events with tedizolid and linezolid: pharmacovigilance insights through the FDA adverse event reporting system.
Gatti M; Fusaroli M; Raschi E; Moretti U; Poluzzi E; De Ponti F
Expert Opin Drug Saf; 2021 Nov; 20(11):1421-1431. PubMed ID: 34280062
[TBL] [Abstract][Full Text] [Related]
7. Early linezolid-associated lactic acidosis in a patient with Child's class C liver cirrhosis and end stage renal disease.
Cheng CN; Lin SW; Wu CC
J Infect Chemother; 2018 Oct; 24(10):841-844. PubMed ID: 29503228
[TBL] [Abstract][Full Text] [Related]
8. Incidence and risk factors of linezolid-induced lactic acidosis.
Im JH; Baek JH; Kwon HY; Lee JS
Int J Infect Dis; 2015 Feb; 31():47-52. PubMed ID: 25499040
[TBL] [Abstract][Full Text] [Related]
9. The association between risk factors and time of onset for thrombocytopenia in Japanese patients receiving linezolid therapy: a retrospective analysis.
Ichie T; Suzuki D; Yasui K; Takahashi H; Matsuda M; Hayashi H; Sugiura Y; Sugiyama T
J Clin Pharm Ther; 2015 Jun; 40(3):279-84. PubMed ID: 25732525
[TBL] [Abstract][Full Text] [Related]
10. Linezolid-induced lactic acidosis: the thin line between bacterial and mitochondrial ribosomes.
Santini A; Ronchi D; Garbellini M; Piga D; Protti A
Expert Opin Drug Saf; 2017 Jul; 16(7):833-843. PubMed ID: 28538105
[TBL] [Abstract][Full Text] [Related]
11. Lactic acidosis associated with standard dose linezolid in a kidney recipient with impaired renal function.
Chen CC; Liu WT; Lin SH
Braz J Infect Dis; 2022; 26(1):101701. PubMed ID: 34942159
[TBL] [Abstract][Full Text] [Related]
12. Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database.
Roberto G; Piccinni C; D'Alessandro R; Poluzzi E
Cephalalgia; 2014 Jan; 34(1):5-13. PubMed ID: 23921799
[TBL] [Abstract][Full Text] [Related]
13. The risk factors of linezolid-induced lactic acidosis: A case report and review.
Mao Y; Dai D; Jin H; Wang Y
Medicine (Baltimore); 2018 Sep; 97(36):e12114. PubMed ID: 30200095
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the risk factors of vomiting during linezolid therapy: a retrospective observational study.
Tsutsumi T; Imai S; Kashiwagi H; Sato Y; Sugawara M; Takekuma Y
Eur J Clin Pharmacol; 2022 Feb; 78(2):279-286. PubMed ID: 34581841
[TBL] [Abstract][Full Text] [Related]
15. Effect of Linezolid on Hematologic Recovery in Newly Diagnosed Acute Myeloid Leukemia Patients Following Induction Chemotherapy.
Nedved AN; DeFrates SR; Hladnik LM; Stockerl-Goldstein KE
Pharmacotherapy; 2016 Oct; 36(10):1087-1094. PubMed ID: 27521990
[TBL] [Abstract][Full Text] [Related]
16. A Case of Linezolid Induced Toxicity.
Tobias PE; Varughese CA; Hanson AP; Gurnani PK
J Pharm Pract; 2020 Apr; 33(2):222-225. PubMed ID: 29911459
[TBL] [Abstract][Full Text] [Related]
17. Reports of Lactic Acidosis Attributed to Metformin, 2015-2018.
Flory JH; Hennessy S; Bailey CJ; Inzucchi SE
Diabetes Care; 2020 Jan; 43(1):244-246. PubMed ID: 31597667
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the risk factors of linezolid-related haematological toxicity in Chinese patients.
Dai Y; Jiang S; Chen X; Han L; Zhang C; Yu X; Zhang X
J Clin Pharm Ther; 2021 Jun; 46(3):807-813. PubMed ID: 33555057
[TBL] [Abstract][Full Text] [Related]
19. Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database.
Welch HK; Kellum JA; Kane-Gill SL
Pharmacotherapy; 2018 Aug; 38(8):785-793. PubMed ID: 29883524
[TBL] [Abstract][Full Text] [Related]
20. Potential for linezolid-related blindness: a review of spontaneous adverse event reports.
Brown J; Aitken SL; van Manen RP
Pharmacotherapy; 2011 Jun; 31(6):585-90. PubMed ID: 21923442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
